Amelioration of spinal cord compressive injury by pharmacological preconditioning with erythropoietin and a nonerythropoietic erythropoietin derivative
Giovanni Grasso(University of Palermo), Francesco Tomasello(University of Catania), Necati Gökmen(University of Messina), Anthony Cerami(Araim Pharmaceuticals (United States)), Domenico Gerardo Iacopino(University of Palermo), Michael Brines(Northwell Health), Thomas R. Coleman(University of Messina), Alessandra Sfacteria(University of Messina), Osman Yılmaz(University of Messina), Marcello Passalacqua(University of Messina), Michele Buemi(University of Messina), Domenico La Torre(University of Messina), Francesco Meli(University of Messina), Serhat Erbayraktar(University of Messina)
Cited by 89
Related Papers
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k
Adiponectin, Metabolic Risk Factors, and Cardiovascular Events among Patients with End-Stage Renal Disease
|Journal of the American Society of Nephrology|2002|764